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Abstract
Background: The incidence of proximal humeral fractures (PHF) increased by more than 30% over the last decade,
which is accompanied by an increased number of operations. However, the evidence on operative vs. non-operative
treatment and post-operative treatments is limited and mostly based on expert opinion. It is mandatory to objectively
assess functional capacity to compare different treatments. Clinical tools should be valid, reliable and sensitive to
change assessing functional capacity after PHFs. This study aimed to analyse inter-rater reliability of the videotaped
Wolf-Motor-Function-Test-Orthopaedic (WMFT-O) and the association between the clinical WMFT-O and the Disability
of the Arm, Shoulder and Hand (DASH) and to determine the sensitivity to change of the WMFT-O and the DASH to
measure functional capacity before and after rehabilitation in PHF patients.
Methods: Fifty-six patients (61.7 ± 14.7 years) after surgical treatment of PHF were assessed using the WMFT-O at two
different time points. To determine inter-rater reliability, the videotaped WMFT-O was evaluated through three blinded
raters. Inter-rater agreement was determined by Fleiss’ Kappa statistics. Pearson correlation coefficients were calculated
to assess the association between the clinical WMFT-O and the video rating as well as the DASH. Sensitivity to change
and responsiveness were analysed for the WMFT-O and the DASH in a subsample of forty patients (53.8 ± 1.4 years)
who were assessed before and after a three week robotic-assisted training intervention.
Results: Inter-rater agreement was indicated by Fleiss’ Kappa values ranging from 0.33–0.66 for functional capacity and
from 0.27–0.54 for quality of movement. The correlation between the clinical WMFT-O and the video rating was higher
than 0.77. The correlation between the clinical WMFT-O and the DASH was weak.
Sensitivity to change was high for the WMFT-O and the DASH and responsiveness was given. In comparison to the
DASH, the sensitivity to change of the WMFT-O was higher.
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Conclusion: The overall results indicate that the WMFT-O is a reliable, sensitive and responsive instrument to measure
more objectively functional change over time in rehabilitation after PHF. Furthermore, it has been shown that video
assessment is eligible for studies to ensure a full blinding of raters.
Trial registration: Clinicaltrials.gov, NCT03100201. Registered on 28 March 2017. The trial was retrospectively registered.
Keywords: Wolf motor function test, Reliability, Sensitivity to change, Responsiveness, Orthopaedic assessment, Shoulder
function, Proximal humeral fracture
Background
The individual and societal burden of musculoskeletal in-
juries, in particular of bone fractures remains to be under-
estimated. Proximal humeral fractures (PHF) are among
the leading causes of functional impairment in patients
after trauma resulting in limitations in basic, instrumental
and advanced activities of daily living. PHFs and wrist
fractures are recognized as the most common fractures of
the upper extremities accounting for more than 20% of
hospital admissions caused by a fracture [1]. In patients
over 40 years of age, the proportion of PHFs increases to
76% [2]. Since 2000 in Germany the incidence of PHFs
has risen from 178 to 246/100.000 inhabitants/year [3]. In
addition, an analysis from Bauer and colleagues showed
that one third of the patients are still integrated into the
work process [4]. Due to the demographic change, a fur-
ther increase in the number of PHFs is expected [5, 6].
This will lead to a significant increase in PHFs requiring
operative or non-operative treatment and post-trauma
hospitalization and rehabilitation.
To date, there is no robust evidence-based consensus
on rehabilitation after PHF regarding standardisation of
content, duration, intensity or frequency [7–9]. One es-
sential requirement to perform controlled studies on sur-
gical and rehabilitation interventions is the availability of
objective, reliable and valid assessments. If possible, these
assessment tools should be blinded to treatment alloca-
tion. To assess functional capacity and task performance
after PHF, at least two types of measures are required:
patient-reported outcomes using questionnaires to assess
activities of daily living and a supervised clinical-based as-
sessment to measure functional capacity of the patients
[10, 11]. The Disability of the Arm, Shoulder and Hand
(DASH) questionnaire is the most commonly used ques-
tionnaire for assessing activities of daily living after shoul-
der and arm injuries [10]. A clinically administered
assessment of the functional capacity including the quality
of movement of PHF patients is the Wolf-Motor-
Function-Test-Orthopaedic (WMFT-O) which has previ-
ously been assessed regarding re-test reliability, inter-rater
reliability, and internal consistency [12]. One further prop-
erty required of an outcome measurement is the sensitiv-
ity to change. It is understood as the ability to describe
changes occurring during a treatment or observational
period. The particular meaning of this property is de-
scribed by the fact that positive changes in a given period
represent the classic therapeutic goal [13]. Beyond asses-
sing functional change in clinical state over time with suf-
ficient sensitivity to change [14–16] clinical-based
assessment tools also need a high responsiveness to decide
if a change over time is clinically meaningful [17, 18]. There
are no studies that examined the sensitivity to change of
the WMFT or the WMFT-O which shows the need to con-
sider also the change over time of the functional capacity
and the quality of movement of the WMFT-O.
The aims of this study were 1st to test the inter-rater
reliability of the videotaped WMFT-O, 2nd to describe
the correlation of the functional capacity assessed by the
WMFT-O and the activities of daily living from a patient
perspective assessed by the DASH questionnaire, and
3rd to describe the sensitivity to change and the respon-
siveness of the WMFT-O and the DASH in a group of
patients with PHFs.
Methods
Patients
For testing inter-rater reliability of the videotaped
WMFT-O two patient populations were assessed. The
first sample was a group of sixteen patients with an age
range from 75 to 90 years with surgical treatment after
PHF [12]. Due to the funding guidelines of the sponsor
of the study (“Deutsche Gesetzliche Unfallversicherung
(DGUV)”) only persons up to 69 could be included into
the intervention study. This decision is based on the
study approach to be able to quickly re-integrate pa-
tients after PHF into everyday work [19]. The second
group consisted of 40 patients with an age range from
34 to 69 years with surgical treatment after PHF partici-
pating in a randomised controlled trail to measure the
effectiveness of robot-assisted training added to conven-
tional rehabilitation [19]. The proximal humeral frac-
tures of both patient groups were surgically fixed by
plate osteosynthesis, screw fixation, endoprostheses or
humeral nails. The second patient group was recruited
at three different clinical sites in Germany and patients
were randomised into an intervention group and a con-
trol group. They were assessed before randomisation
(baseline) and after completing an intervention period of
Nerz et al. BMC Musculoskeletal Disorders          (2019) 20:315 Page 2 of 8
3 weeks (reassessment). At baseline, cognition was
assessed by the Short Orientation-Memory-
Concentration Test [20] as well as visual acuity, gait
speed (10-m walk [21]), level of pain in the affected arm,
ability to work, disability of the arm, shoulder and hand
(DASH [22]), range of motion of the affected arm (goni-
ometer measurement [23]), and motor function of the
affected arm and shoulder (WMFT-O; [12]). Clinical re-
assessment directly after the intervention assessed dis-
ability of the arm, shoulder and hand (DASH) as well as
range of motion and functional capacity (WMFT-O).
The WMFT-O was videotaped at both time points. To
analyse the sensitivity to change and the responsiveness
of the WMFT-O the second subsample with 40 patients
was analysed. Both studies were approved by the ethical
committee of the University of Tübingen and are in
agreement with the Declaration of Helsinki. All partici-
pants gave written informed consent.
Outcome measures
The WMFT-O is an adapted version of the basic
WMFT [24] with good clinical inter- and intra-rater reli-
ability. The modified version for shoulder injuries was
developed by our group [12]. The WMFT was developed
to measure functional improvement between the begin-
ning and the end of therapy. The WMFT-O is super-
vised and includes 20 arm motion tasks used in daily
living that are evaluated in terms of functional capacity
and quality of movement. The single items are progres-
sing from coarse movements in the elbow and shoulder
area to more complex and dexterous tasks in the fingers
and the hand area. The endpoint is a total score
calculated from the ratings of the functional capacity
and the quality of movement (5 is the best value, 0 the
worst). The total WMFT-O score ranges from 0 to 100
points with lower scores indicating greater disability
(Additional file 1: Video tutorial Rating Scale of the
WMFT-O: https://youtu.be/WQUSl2XQJMY and
Additional file 2: Video tutorial performance instruc-
tions of the WMFT-O: https://youtu.be/K6g3Z_
ibNa8). First a clinical rating was performed by pre-
trained assessors. As a next step each videotaped
WMFT-O (baseline and reassessment, n = 112) was
assessed by three out of five pre-trained raters (4
physiotherapists, 1 occupational therapist).
The first module of the DASH questionnaire was
used to measure self-perceived activity and limitation of
shoulder, arm and hand function [22]. The DASH is
considered as a valid and reliable non-supervised test
[25–28]. The questionnaire consist of 30 questions to as-
sess the restrictions related to the function and activity
of the shoulder, arm and hand in daily living, as well as
self-esteem and potentially existing symptoms of the
shoulder, arm and hand, such as pain or prickle. The
endpoint is a total score calculated from the ratings of
the individual responses (1 is the best value, 5 the
worst). The total DASH score ranges from 0 to 100
points with higher scores indicating greater disability.
Data analysis
All statistics and outcome analyses were performed
using RStudio software (Version 1.1.383). The inter-rater
agreement of the video rating was determined by Fleiss’
Kappa statistics with corresponding confidence intervals
(CI). Pearson correlation coefficients were calculated to
assess the association between the WMFT-O clinical rat-
ing and the video rating as well as between the WMFT-
O clinical rating and the DASH questionnaire.
Sensitivity to change was defined as the ability of an in-
strument to respond to changes in the measured con-
struct, regardless of whether the change is relevant or
meaningful to the decider [14, 18]. In order to analyse
the sensitivity to change of the WMFT-O, the change
scores and the standardized effect size as well as the
standardized response mean [29] were calculated.
Change scores imply the delta of the results between the
baseline- and reassessment. This score represents the ex-
tent of which a patient changes in performance in the cor-
responding test. The Wilcoxon test was calculated to
compare the baseline and the reassessment score (p > 0.01).
The standardized effect size was calculated by dividing the
change score by the standard deviation of the baseline score
[30]. The standardized response mean was calculated by
dividing the change score by the standard deviation of that
change score [31]. Values < 0.01 for the standardized effect
size are considered as very small, < 0.2 as small, < 0.5
as medium, < 0.8 as large, < 1.2 as very large and < 2.0
as huge [32]. Husted and colleagues [29] interpreted
the values of the standardized effect size and the stan-
dardized response mean considering the same bench-
marks (< 0.2 for trivial, 0.2 to< 0.5 for small, 0.5 to< 0.8
for moderate, and 0.8 or greater for large). Cohen’s
threshold values are > 0.8 equates to large, > 0.5 to
medium and > 0.2 to small effect sizes and intended for
intervention studies, but are sometimes used to apply
sensitivity to change of questionnaires [31].
Responsiveness was defined as the ability of an instru-
ment to measure a meaningful or important change in a
clinical state [14, 18] and is usually reported through the
minimal important difference [33, 34]. For being consid-
ered as important, a change score of a measure should
equal or exceed its minimal important difference esti-
mate. Minimal important difference values were calcu-
lated using two commonly used effect size estimates in
the literature: 0.3* standard deviation of the baseline
score and 0.5* standard deviation of the baseline score
[34, 35].
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Results
The study sample consisted of two groups. The first sub-
sample included 16 older patients with a mean age of
81.4 years (range 75–90 years). The second subsample
includes 40 younger patients with a mean age of 53.8
years (range 39–69 years). The subject characteristics are
listed in Table 1.
Inter-rater reliability of the videotaped WMFT-O
Table 2 lists inter-rater reliability across all items of the
videotaped WMFT-O. The Fleiss’ Kappa values ranged
between 0.35 and 0.67 (CI = 0.27 to 0.73) for the func-
tional capacity and between 0.27 and 0.54 (CI = 0.21 to
0.60) for the quality of movement. Grip strength (task
15) was not considered since the task could not be ana-
lysed from the video recordings.
Correlation between the WMFT-O clinical and video
rating and the DASH
Pearson correlation coefficients (r) of the WMFT-O clin-
ical rating and the video rating were high for all three
raters and highly significant (functional capacity and
quality of movement r≥ 0.82, p < 0.001) (Fig. 1). After re-
ducing missing or occluded video recordings, the Pear-
son correlation coefficient for the functional capacity
could be calculated for 49 subjects and for 48 subjects
for the quality of movement. Due to the uniform results
of the three different raters, in Fig. 1 only the ratings of
the first rater are shown.
The correlation between the WMFT-O clinical rating
and the DASH questionnaire was significantly weak at
baseline (functional capacity r = − 0.27 and quality of
movement r = − 0.32, p < 0.05) (Fig. 2). The Pearson cor-
relation coefficient for the DASH could be calculated for
56 subjects.
Sensitivity to change and responsiveness
The sensitivity to change and the responsiveness indices
of the WMFT-O and DASH are listed in Table 3. For
the WMFT-O the clinical rating was carried out locally
in the individual study centres by one trained rater and
the DASH was completed by the subject himself on site.
The baseline and the reassessment scores for the
WMFT-O functional capacity and quality of movement
as well as the DASH differ significantly from each other
(p < 0.01). The WMFT-O and the DASH demonstrated
large standardized effect sizes, ranging between 0.8 and
0.9 (Table 3). Large standardized response means were
also obtained for the WMFT-O functional capacity,
quality of movement and the DASH. The standardized
response mean for the DASH was slightly less sensitive
to change when compared to the WMFT-O functional
capacity and quality of movement. The minimal import-
ant differences for the WMFT-O functional capacity
ranged between 5.0 (0.3* standard deviation of the base-
line score) and 8.3 (0.5* standard deviation of the base-
line score) and for the WMFT-O quality of movement
between 6.3 (0.3* standard deviation of the baseline
score) and 10.5 (0.5* standard deviation of the baseline
score) and are comparable to the minimal important dif-
ferences of the DASH (Table 3).
Discussion
Our study on patients with fractures of the proximal hu-
merus demonstrated high sensitivity to change and good
responsiveness of the orthopaedic Wolf-Motor-Function-
Test indicating its usefulness as a functional capacity as-
sessment tool in operative and rehabilitation studies.
This study also found moderate inter-rater reliability
for the videotaped version of the WMFT-O (Table 2).
According to Landis and Koch [36] the calculated Fleiss’
Table 1 Participant demographics
Characteristic 1st Subsample 2nd Subsample Total sample
Subjects (n) 16 40 56
Gender
Female (%) 13 (81.2%) 25 (62,5%) 38 (67.9%)
Age (years)
Mean (SD) 81.4 (1.1) 53.8 (1.4) 61.7 (14.7)
Minimum 75 39 39
Maximum 90 69 90
Affected Arm
Right (%) 10 (62.5%) 17 (42.5%) 27 (48.2%)
Arm Dominance a
Left (%) 1 (6.3%) 5 (12.5%) 6 (10.9%)
Right (%) 15 (93.7) 34 (85.0%) 49 (89.1%)
Dominant arm affected (%) 9 (56.3%) 17 (42.5%) 26 (47.3%)
n Number, SD Standard deviation; aDominant arm could not be determined in one subject.
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Кappa values for the functional capacity and quality of
movement can be interpreted as a fair to substantial
agreement. The observed agreements were weaker than
in a previous clinical study using a non-videotaped as-
sessment of WMFT-O in similar patients [12]. Another
publication investigating the reliability of the neuro-
logical based WMFT-N version [37] also had higher
interrater agreement. The lower agreement of the video-
taped measurement could have several reasons. Possibly
the training session of the video raters were not enough.
A further explanation for the lower agreement could
also be an inadequate positioning of the chosen video
camera and a different camera position might lead to
better results. The performance of the tasks on such
videos (e.g. in task 16- “Turn key in lock frontal”, Fleiss’
Kappa for functional capacity =0.33 and quality of move-
ment =0.27; Table 2) was not easy to identify which re-
sulted in more diverse ratings between the raters.
Moreover, an inadequate description of the correct end-
position in task 1 (“Forearm to table lateral”, Fleiss’
Kappa functional for capacity =0.41 and quality of move-
ment =0.30; Table 2) lead to different opinions about ful-
filling or not fulfilling the task. A possible solution could
be reducing the prescribed tasks to improve rater agree-
ment. The tasks that were poorly rated could potentially
be omitted and a future short version of the WMFT-O
could be provided. According to Landis and Koch [36],
an inter-rater reliability of 0.01 to 0.20 is considered as a
Table 2 Inter-rater reliability across all items of the video WMFT-O; n = 56 (p < 0.005)
Task Functional Capacity Quality of Movement
Inter-rater reliability
Fleiss’ Kappa (95% CI)
Inter-rater reliability
Fleiss’ Kappa (95% CI)
1. Forearm to table lateral 0.41 (0.35–0.48) 0.30 (0.24–0.37)
2a/b. Forearm to box 15/30 cm lateral 0.47 (0.41–0.53) 0.39 (0.34–0.44)
3. Forearm to box lateral with weight 0.64 (0.57–0.71) 0.54 (0.48–0.60)
4. Extend elbow lateral 0.49 (0.44–0-55) 0.46 (0.41–0.51)
5. Extend elbow lateral with weight 0.56 (0.50–0.62) 0.43 (0.38–0.49)
6. Hand to table frontal 0.60 (0.53–0.67) 0.38 (0.32–0.45)
7a/b. Hand to box 15/30 cm frontal 0.55 (0.49–0.61) 0.51 (0.46–0.57)
8. Hand to box frontal with weight 0.67 (0.60–0.73) 0.53 (0.48–0.59)
9. Reach and retrieve frontal 0.49 (0.43–0.55) 0.44 (0.37–0.50)
10. Lift can frontal 0.59 (0.52–0.65) 0.50 (0.44–0.56)
11. Lift pencil frontal 0.60 (0.53–0.67) 0.45 (0.38–0.51)
12. Lift paper clip frontal 0.51 (0.45–0.58) 0.39 (0.32–0.45)
13. Stack checkers frontal 0.50 (0.44–0.57) 0.34 (0.27–0.40)
14. Flip cards frontala 0.49 (0.43–0.56) 0.37 (0.30–0-43)
16. Turn key in lock frontal 0.35 (0.27–0.42) 0.27 (0.21–0.33)
17. Fold towel frontal 0.49 (0.42–0.55) 0.42 (0.36–0.47)
18. Lift basket frontal 0.47 (0.41–0.53) 0.43 (0.37–0.48)
CI Confidence Interval, a task 15 (grip strength) was omitted.
Fig. 1 Correlation of the WMFT-O functional capacity and quality of movement clinical rating and video rating (FC Functional capacity, QoM
Quality of movement; Pearson correlation coefficient (r); p < 0.001)
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slight agreement and 0.21 to 0.40 as a fair agreement. If
these values were used as a basis to decide which items of
the WMFT-O could be deleted in a short version, this
would delete task 1 and 16 due to the low inter-rater reli-
ability of the functional capacity and quality of movement
as well as task 2ab, 12, 13 and 14 due to the low inter-
rater reliability of the quality of movement (Table 2).
A third aspect is the calculation of different statistical
measures. Inter-rater agreement for two different raters,
as calculated in Oberle and colleagues 2018 [12] should
be determined by weighted Cohen’s Kappa (Кw) statis-
tics [38]. For three or more raters, Fleiss’ Kappas is rec-
ommended as the method of choice. The Fleiss’ Kappa
assumes that the examiners were randomly selected
from a group of available examiners. Cohen’s Kappa, on
the other hand, assumes that examiners have been spe-
cifically selected and trained. Therefore, the probability
of agreement in the Fleiss’ Kappa and the Cohen’s Kappa
is estimated in different ways. In some cases, Fleiss’
Kappa in general may produce lower values even if the
agreement is actually high as described before [39]. That
in turn may be a possible explanation why the inter-
rater reliability values of the video-based WMFT-O cal-
culated by Fleiss’ Kappa (Table 2) were lower than the
inter-rater reliability values of the clinically WMFT-O as
reported by Oberle and colleagues [12] and calculated
by Cohen’s Kappa.
We found a very strong correlation between the
WMFT-O clinical baseline rating and the video baseline
ratings for the functional capacity and a strong correlation
for the quality of movement according to the standards of
Evans [40].
To assess treatment effects of interventions for muscu-
loskeletal conditions, functional capacity and personal
activity need to be evaluated. Therefore, the WMFT-O
has to be augmented by other methods to evaluate levels
of disability, activity and participation. A widely applied
method is the DASH. It is expected that the correlation
between activity levels and functional capacity is often
less than anticipated. The correlation between the
clinical-based measures (WMFT-O clinical rating of the
functional capacity and the quality of movement) and
the patient-reported questionnaires (DASH) at baseline
was indeed weak [40]. One aspect is that patients do not
return to their activity levels due to psychological prob-
lems such as insufficient self-efficacy. Other aspects are
methodological problems. The DASH is not explicitly
designed for the affected arm. This means that in in-
stances where tasks are mostly carried out with the
dominant hand (e.g. turning a key in a lock) the restric-
tion in the non-dominant arm, shoulder and hand are
not necessarily being captured through the DASH. This
is only the case if the affected hand is also the dominant
hand. This misjudgement could be avoided if care is
taken that when answering the questions of the DASH,
the assessment of the restriction always relates to the
performance of the activity with the affected shoulder,
arm or hand. If it is not possible to carry out the activity
of daily living with the affected shoulder, arm or hand
the patient must be able to imagine the execution of the
Fig. 2 Correlation of the WMFT-O functional capacity and quality of movement clinical rating and DASH (FC Functional capacity, QoM Quality of
movement; Pearson correlation coefficient (r); p < 0.05)
Table 3 Sensitivity to change and responsiveness of the clinical WMFT-O and DASH; n = 40
Parameter Baseline Mean (SD) Reassessment Mean (SD) CS (SD) SES SRM MID (0.3SDb) MID (0.5SDb)
WMFT-O
FC 54.3 (16.5) 69.2 (12.8) 14.9 (10.1) 0.9 1.5 5.0 8.3
QOM 57.7 (20.9) 76.1 (14.8) 18.4 (14.1) 0.9 1.3 6.3 10.5
DASH 51.9 (20.0) 36.7 (16.6) −15.2 (12.6) 0.8 1.2 6.0 10.0
SD Standard deviation, CS Change score, SES Standardized effect size, SRM Standardized response mean, MID Minimally important difference, SDb Standard
deviation Baseline, WMFT-O Wolf-Motor-Function-Test-Orthopaedic, FC Functional capacity, QoM Quality of Movement.
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activity of daily living and the possible restrictions as
best as possible and then answer the question.
One study from Wu and colleagues [41] developed the
streamlined WMFT which includes the performance rat-
ing of 6 timed tasks for neurological patients. They
found a low effect size for the streamlined WMFT and
the original WMFT [41]. In comparison to this study the
WMFT-O had a large effect size for both the functional
capacity and the quality of movement and can thus be
regarded as being sensitive to change over time accord-
ing to the published standards [29, 32]. This result was
confirmed by the absolute values of the standardized re-
sponse mean, which can be considered higher than the
standardized effect sizes for both the functional capacity
and the quality of movement. This is a relevant finding
in terms of clinical use to provide a more objective and
sensitive measure for assessing functional capacity and
quality of movement of the upper extremities for pa-
tients in orthopaedic rehabilitation and may improve
current assessments which currently are mostly subject-
ive. Compared to the WMFT-O, the sensitivity to
change of the DASH was lower. These findings indicate
that the WMFT-O is a more sensitive outcome measure
for assessing functional change over time through re-
habilitation in patients with PHF. MacDermid and col-
leagues [42] and Westhphal and colleagues [11]
determined the sensitivity to change of the DASH for
patients after wrist fractures. They found higher values
for the effect size of the DASH in patients with wrist
fractures after 0–3 months. After 3–12months they ob-
served to be somewhat lower [11]. This indicates that
the standardized effect sizes and standardized response
mean depend on the point of time of the baseline- and
reassessment. In the first 12 weeks after baseline, a large
treatment effect can be expected. The next three quar-
ters might lead to further improvements but the effect
sizes will be smaller. In our study, the baseline assess-
ment was conducted approximately one month after sur-
gery. In order to find out whether the WMFT-O can
also be used to assess long-term therapy results, a future
study should be carried out including longer therapy in-
tervals assessing upper extremity functional capacity
measured with the WMFT-O after three month. A simi-
lar relation was found for the DASH questionnaire. In
conclusion, both the WMFT-O and the DASH are re-
sponsive and complimentary assessment instruments in
order to measure the functional change in patients with
PHF.
Conclusion
The WMFT-O is a responsive instrument to objectively
measure patient functional change in younger and older
patients with PHF. It showed a somewhat higher sensi-
tivity to change in younger and older patients with PHF
compared to the DASH. For assessing treatment success
of interventions and rehabilitation functional capacity
could be measured by the WMFT-O but it should be aug-
mented by another method (for example the DASH) to
enable the evaluation of levels of disability, activity and
participation. We recommend minor modifications of the
camera positions and of the descriptions of some move-
ment tasks for the videotaped WMFT-O. After a detailed
training of the rater and taking into account these changes
we also recommend the application of a video based as-
sessment as this would allow robust blinding of assessors
which often is not the case due to contamination of thera-
pists and assessment staff. Furthermore a short version of
the WMFT-O would be desirable.
Additional files
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(MP4 6957 kb)
Additional file 2: Video tutorial performance instructions of the WMFT-
O. Video tutorial with detailed instructions how to perform the single
items of the WMFT-O in English. (MP4 21016 kb)
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